COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,711 Articles (22,913 medRxiv, 8,798 bioRxiv)

Most recent first Previous |  Page 512: Articles 5111-5120  | Next

Index Cases First Identified by Nasal-Swab Rapid COVID-19 Tests Had More Transmission to Household Contacts Than Cases Identified by Other Test Types
Ji, J., Viloria Winnett, A., Shelby, N., Reyes, J. A., Schlenker, N. W., Davich, H., Caldera, S., Tognazzini, C., Goh, Y.-Y., Feaster, M., Ismagilov, R. F.
10.1101/2023.03.09.23286855 — Posted: 2023-03-10
Spatio-temporal distributions of COVID-19 vaccine doses uptake in the Netherlands: A Bayesian ecological modelling analysis
Wang, H., Varol, T., Gultzow, T., Zimmermann, H. M. L., Ruiter, R. A. C., Jonas, K. J.
10.1101/2023.03.09.23287033 — Posted: 2023-03-10
Cause of Death by Race and Ethnicity in Minnesota Before and During the COVID-19 Pandemic, 2019-2020
Blake, M., Marka, N., Steer, C., Ravdin, J.
10.1101/2023.03.09.23287048 — Posted: 2023-03-10
Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses
Maestri, R., Perez-Lamarque, B., Zhukova, A., Morlon, H.
10.1101/2023.03.09.531875 — Posted: 2023-03-09
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
Grant, M. D., Bentley, K., Fielding, C. A., Hatfield, K. M., Ings, D. P., Harnum, D., Wang, E., Stanton, R., Holder, K. A.
10.1101/2023.03.09.531709 — Posted: 2023-03-09
Characterization of Long COVID among U.S. Medicare Beneficiaries using Claims Data
Lu, Y., Lindaas, A., Izurieta, H. S., Cozen, M., Menis, M., Shi, X., Steele, W., Wernecke, M., Chillarige, Y., Kelman, J. A., Forshee, R. A.
10.1101/2023.03.07.23286107 — Posted: 2023-03-09
What the analysis of causes of death in France in 2020 reveals about the impact of the Covid-19 epidemic
Toubiana, L., Mucchielli, L., Bouaud, J., Chaillot, P.
10.1101/2023.03.07.23286673 — Posted: 2023-03-09
Covid-19 impact on food insecurity in Uganda: a dynamic analysis
Ubabukoh, C. L., Tampubolon, G.
10.1101/2023.03.07.23286899 — Posted: 2023-03-09
Archetypal analysis of COVID-19 in Montana, USA, March 13, 2020 to April 26, 2022
Stone, E., Landguth, E., Coombs, S.
10.1101/2023.03.06.23286886 — Posted: 2023-03-09
Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 1 immunoglobulins: a phase I/II dose finding study
Huygens, S., Preijers, T., Swaneveld, F. H., Kleine Budde, I., GeurtsvanKessel, C., Koch, B. C. P., Rijnders, B. J. A.
10.1101/2023.03.07.23286893 — Posted: 2023-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).